Condition

Stage IVB Colorectal Cancer

ClinicalTrials.gov condition label

Clinical trials3

Recruiting0

Common interventions10

Lead sponsors shown3

Clinical trials

3 shown

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersNCT03112668 · 2017-12-06

COMPLETED

S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)NCT02728596 · 2016-10-07

COMPLETED

TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsNCT02650635 · 2016-02-05

TERMINATED

Common interventions

Quality-of-Life AssessmentOTHER2Questionnaire AdministrationOTHER2Cognitive Behavior TherapyBEHAVIORAL1CyclophosphamideDRUG1Laboratory Biomarker AnalysisOTHER1PegfilgrastimBIOLOGICAL1Pharmacological StudyOTHER1Preventive InterventionOTHER1Survey AdministrationOTHER1TLR8 Agonist VTX-2337DRUG1

Leading sponsors

Mayo Clinic1Rutgers, The State University of New Jersey1SWOG Cancer Research Network1

Trial status mix

COMPLETED2

TERMINATED1

Phase mix

NA2

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.